Doctors, scientists call for probe of guidelines on cholesterol-lowering drugs

09/24/2004 | SeattlePI.com

Thirty-five doctors and scientists have joined with a consumer group in calling for a federal investigation of the science that led to guidelines urging greater use of cholesterol-lowering statin drugs. In a letter to the NIH, the writers say there is inadequate evidence to justify the broad recommendations, and a consumer group says the recommendation is tainted because eight of the nine panelists on the committee issuing the guidelines have financial interests with the drugs' makers.

View Full Article in:

SeattlePI.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Chief Executive Officer
UCare Minnesota
Minneapolis, MN
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC